BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1740205)

  • 1. Leuprolide acetate-prepared in vitro fertilization-gamete intrafallopian transfer cycles: efficacy versus controls and cost analysis.
    Corson SL; Batzer FR; Gocial B; Eisenberg E; Huppert LC; Nelson JR
    Fertil Steril; 1992 Mar; 57(3):601-5. PubMed ID: 1740205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins for in vitro fertilization or gamete intrafallopian transfer.
    Ferrier A; Rasweiler JJ; Bedford JM; Prey K; Berkeley AS
    Fertil Steril; 1990 Jul; 54(1):90-5. PubMed ID: 2113492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of the controlled ovarian hyperstimulation using GnRH agonist and pure FSH in in vitro fertilization-embryo transfer and gamete intrafallopian transfer program].
    Usui A
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1431-8. PubMed ID: 2511261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of a modified gonadotropin-releasing hormone agonist long protocol in an in vitro fertilization program.
    Pantos K; Meimeth-Damianaki T; Vaxevanoglou T; Kapetanakis E
    Fertil Steril; 1994 Apr; 61(4):709-13. PubMed ID: 8150115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian response and pregnancy rates in in vitro fertilization, gamete intrafallopian transfer, and in vivo fertilization therapies after combined gonadotropin-releasing hormone agonist/human menopausal gonadotropin stimulation.
    Lindner C; Braendle W; Lichtenberg V; Köhler S; Bettendorf G
    Gynecol Obstet Invest; 1990; 29(2):140-4. PubMed ID: 2139861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular stimulation for in vitro fertilization using pituitary suppression and human menopausal gonadotropins.
    Awadalla SG; Friedman CI; Chin NW; Dodds W; Park JM; Kim MH
    Fertil Steril; 1987 Nov; 48(5):811-5. PubMed ID: 3117593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
    Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
    Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of cryopreserved pre-embryos obtained in in vitro fertilization cycles with or without a gonadotropin-releasing hormone agonist.
    Oehninger S; Toner JP; Veeck LL; Brzyski RG; Acosta AA; Muasher SJ
    Fertil Steril; 1992 Mar; 57(3):620-5. PubMed ID: 1740208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials.
    Hughes EG; Fedorkow DM; Daya S; Sagle MA; Van de Koppel P; Collins JA
    Fertil Steril; 1992 Nov; 58(5):888-96. PubMed ID: 1426372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization.
    Segal S; Casper RF
    Fertil Steril; 1992 Jun; 57(6):1254-8. PubMed ID: 1601147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles.
    Daya S
    Cochrane Database Syst Rev; 2000; 2000(2):CD001299. PubMed ID: 10796763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leuprolide acetate elevates prolactin during ovarian stimulation with gonadotropins.
    Meldrum DR; Cedars MI; Hamilton F; Huynh D; Wisot A; Marr B
    J Assist Reprod Genet; 1992 Jun; 9(3):251-3. PubMed ID: 1525456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized study of human menotropin versus a follicular and a luteal phase gonadotropin-releasing hormone analog-human menotropin stimulation protocols for in vitro fertilization.
    Maroulis GB; Emery M; Verkauf BS; Saphier A; Bernhisel M; Yeko TR
    Fertil Steril; 1991 Jun; 55(6):1157-64. PubMed ID: 1903732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The advantages of a gonadotropin releasing hormone agonist (leuprolide acetate) in conjunction with gonadotropins for controlled ovarian hyperstimulation in IVF and GIFT cycles.
    Kerin JF
    Arch Gynecol Obstet; 1989; 246 Suppl():S45-52. PubMed ID: 2511810
    [No Abstract]   [Full Text] [Related]  

  • 15. WITHDRAWN: Gonadotrophin-releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles.
    Daya S
    Cochrane Database Syst Rev; 2007 Jul; (1):CD001299. PubMed ID: 17636664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.
    Droesch K; Muasher SJ; Brzyski RG; Jones GS; Simonetti S; Liu HC; Rosenwaks Z
    Fertil Steril; 1989 Feb; 51(2):292-7. PubMed ID: 2492234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delay of gonadotropin stimulation in patients receiving gonadotropin-releasing hormone agonist (GnRH-a) therapy permits increased clinic efficiency and may enhance in vitro fertilization (IVF) pregnancy rates.
    Damario MA; Moomjy M; Tortoriello D; Moy F; Davis OK; Rosenwaks Z
    Fertil Steril; 1997 Dec; 68(6):1004-10. PubMed ID: 9418688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant leuprolide in normal, abnormal, and poor responders to controlled ovarian hyperstimulation for in vitro fertilization/gamete intrafallopian transfer.
    Sathanandan M; Warnes GM; Kirby CA; Petrucco OM; Matthews CD
    Fertil Steril; 1989 Jun; 51(6):998-1006. PubMed ID: 2498135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study.
    Younis JS; Simon A; Koren R; Dorembus D; Schenker JG; Laufer N
    Fertil Steril; 1992 Sep; 58(3):575-80. PubMed ID: 1387849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
    Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G
    J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.